Abstract
The 1950s ad slogan “better living through chemistry” provides an interesting starting point for this chapter on drug abuse assessment. It is particularly fitting in a time when public sentiment about substance use has never been more ambivalent. At once, society both looks for chemical cures for problems and at the same time tries to eradicate “drug culture.” The substances that we often turn to for help, healing, and stress relief are increasingly themselves problematic. Substance use touches all of us because although drug abuse may involve illegal behavior, many substances of abuse are covertly sanctioned and promoted and others are both legal and openly promoted for controlled use in our society (Goldstein, 2001). These contradictions may contribute to the confusion so many mental health practitioners appear to experience over the assessment of substance use and abuse. In this arena, as much as any other set of disorders, it is particularly important to remain cognizant of the ambivalence we may experience as participants in our own cultural and personal contexts. It is with this in mind that the reader is invited to consider the artificial nature of distinctions between legal, illegal, over the counter, and prescription substances. This chapter concerns substances of abuse other than alcohol, which is addressed in a separate chapter. The present chapter discusses drugs of abuse, their costs, common terms, recent use statistics, diagnostic criteria, a case illustration, procedures for gathering information, commonly used standardized interview formats and tools, and “dos and don’ts” to keep in mind in the diagnostic interview.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
American Society of Addiction Medicine. (2001). Patient placement criteria for the treatment of substancerelated disorders, Second Edition—Revised (ASAM PPC-2R). Washington, DC: Author.
Bastiens, L., Francis, G., & Lewis, K. (2000). The RAFFT as a screening tool for adolescent substance use disorders. American Journal on Addictions, 9,10–16.
Brady, S., Hiam, C. M., Saemann, R., Humbert, L., Fleming, M. Z., & Dawkins-Brickhouse, K. (1996). Dual-diagnosis: A treatment model for substance abuse and major mental illness. Community Mental Health Journal,32, 573–578.
Center for Substance Abuse Treatment. (1999). Enhancing motivation for change in substance abuse treatment (Treatment Improvement Protocol [TIP] Series). Washington, DC: U.S. Government Printing Office.
Center for Substance Abuse Treatment. (2001). The role and current status of patient placement criteria in the treatment of substance use disorders (Treatment Improvement Protocol [TIP] Series). Washington, DC: U.S. Government Printing Office.
Cooney, N. L., Zweben, A., & Fleming, M. E (1995). Screening for alcohol problems and at-risk drinking in health-care settings. In R. K. Hester & W. R. Miller (Eds.), Handbook of alcoholism treatment approaches: Effective approaches (2nd ed., pp. 45–60). Boston: Allyn & Bacon.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). User’s guide to the Structured Clinical Interview for DSM-IV Axis I Disorders: Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
Fisher, G. L., & Harrison, T. C. (2000). Substance abuse: Information for school counselors, social workers,therapists, and counselors (2nd ed.). Boston: Allyn & Bacon.
Goldstein, A. (2001). Addiction: From biology to drug policy (2nd ed.). New York: Oxford University Press.
Gordon, J. U. (Ed.). (1994). Managing multiculturalism in substance abuse services. Thousand Oaks, CA: Sage.
Julien, R. M. (1997). A primer of drug action: A concise, nontechnical guide to the actions, uses,and side effects of psychoactive drugs (8th ed.). New York: Freeman.
Leshner, A. I. (1999). Science-based views of drug addiction treatment. Journal of the American Medical Association, 282, 1314–1316.
McEvoy, A. W., Kitchen, N. D., & Thomas, D. G. T. (1998). Intracerebral hemorrhage caused by drug abuse. Lancet, 351,1029–1030.
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., et al. (1992). The Addiction Severity Index (5th ed.). Journal of Substance Abuse Treatment, 9, 199–213.
McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Diseases, 168, 26–33.
Miller, G. A. (1997). The Substance Abuse Subtle Screening Inventory-3 manual. Spencer, IN: Spencer Evening World.
Miller, S. D., & Berg, I. K. (1992). Working with the problem drinker. New York: Norton.
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
Minkoff, K. (1998). Individuals with co-occurring psychiatric and substance disorders in managed care systems: Standards of care, practice guidelines, workforce competencies and training curricula. University of Pennsylvania Center for Mental Health Policy and Services Research. Available from www.upenn.edu/cmhpsr.
Minkoff, K. (2000). State of Arizona service planning guidelines: Co-occurring psychiatric and substance disorders (edited version). Acton, MA: Author.
National Institute on Drug Abuse. (1998a). Methamphetamine abuse and addiction. National Institute on Drug Abuse Research Report Series (NIH Publication No. 98–4210). Washington, DC: U.S. Department of Health and Human Services.
National Institute on Drug Abuse. (1998b). Nicotine addiction. National Institute on Drug Abuse Research Report Series (NIH Publication No. 98–4342). Washington, DC: U.S. Department of Health and Human Services.
National Institute on Drug Abuse. (1999). Cocaine abuse and addiction. National Institute on Drug Abuse Research Report Series (NIH Publication No. 99–4342). Washington, DC: U.S. Department of Health and Human Services.
National Institute on Drug Abuse. (2000a). Anabolic steroid abuse. National Institute on Drug Abuse Research Report Series (NIH Publication No. 00–3721). Washington, DC: U.S. Department of Health and Human Services.
National Institute on Drug Abuse. (2000b). Heroin abuse and addiction. National Institute on Drug Abuse Research Report Series (NIH Publication No. 00–4165). Washington, DC: U.S. Department of Health and Human Services.
National Institute on Drug Abuse. (2000c). Inhalant abuse. National Institute on Drug Abuse Research Report Series (NIH Publication No. 00–3818). Washington, DC: U.S. Department of Health and Human Services.
Northwest Frontier Addiction Technology Transfer Center. (2001). Performance assessment rubrics for the addiction counseling competencies (Oregon Office of Alcohol and Drug Abuse Programs). Salem: Author.
Office of National Drug Control Policy. (2001). The economic costs of drug abuse in the United States, 1992–1998 (Publication No. NCJ-190636). Washington, DC: Executive Office of the President.
Ott, P. J., Tarter, R. E., & Ammerman, R. T. (1999). Sourcebook on substance abuse: Etiology, epidemiology, assessment, and treatment. Boston: Allyn & Bacon.
Prochaska, J. O., & DiClemente, C. C. (1991). Stages of change in the modification of problem behaviors. In M. Hersen, R. M. Eisler, & P. M. Miller (Eds.), Progress in behavior modification (Vol. 27, pp. 184–214). Newbury Park, CA: Sage.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change: Applications to addictive behaviors. American Psychologist, 47, 1102–1114.
Riehman, K. S., Hser, Y.-I., & Zeller, M. (2000). Gender differences in how intimate partners influence drug treatment motivation. Journal of Drug Issues, 30, 823–839.
Robert Wood Johnson Foundation. (2001). Substance abuse: The nation’s number one health problem: Key indicators for policy. Princeton, NJ: Author.
Rosengren, D. B., Downey, L., & Donovan, D. M. (2000). I already stopped: Abstinence prior to treatment. Addiction, 95, 65–77.
Spittal, P. M., & Schechter, M. T. (2001). Injection drug use and despair through the lens of gender. Canadian Medical Association Journal, 164,802–804.
Substance Abuse and Mental Health Services Administration. (1999). National household Survey on Drug Abuse: Population estimates, 1999. Retrieved May 13, 2002, from www.samhsa.gov/OAS/NHSDA/ tobacco /highlights.htm.
Substance Abuse and Mental Health Services Administration. (2000). National Household Survey on Drug Abuse: Population estimates, 2000. Retrieved May 13, 2002, from www.samhsa.gov/oas /NHSDA/2kNHSDA/highlights.htm.
Tarter, R. E. (1990). Evaluation and treatment of adolescent substance abuse: A decision tree method. American Journal of Drug and Alcohol Abuse, 16, 1–46.
Tarter, R. E., & Hegedus, A. M. (1991). The Drug Use Screening Inventory. Alcohol health and Research World, 15, 65–76.
Vastag, B. (2001). Mixed message on prescription drug abuse. Journal of the American Medical Association, 285, 2183–2184.
Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001). Integrating primary care with addiction treatment: A randomized controlled trial. Journal of the American Medical Association, 286, 1715–1723.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Antick, J., Goodale, K. (2003). Drug Abuse. In: Hersen, M., Turner, S.M. (eds) Diagnostic Interviewing. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4963-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4963-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4965-6
Online ISBN: 978-1-4757-4963-2
eBook Packages: Springer Book Archive